Information Provided By:
Fly News Breaks for October 24, 2019
INCY
Oct 24, 2019 | 14:00 EDT
JMP Securities analyst Reni Benjamin reiterated an Outperform rating and $110 price target on Incyte Corporation, with the analyst citing a discounted EPS and revenue multiple analysis and the potential of the company's rux cream for vitiligo, following its positive 52-week Phase 2 results from last week.
News For INCY From the Last 2 Days
There are no results for your query INCY